Understanding how Transcranial Magnetic Stimulation helps treat depression in Veterans
Official title: Modeling the Treatment Response of Transcranial Magnetic Stimulation for Depression
Funded at Providence VA Medical Center · NIH-11043390 · Data updated 2026-11-12
This study is looking at how well Transcranial Magnetic Stimulation (TMS) can help Veterans with Major Depressive Disorder who haven't found relief from regular medications, aiming to find the best ways to make this treatment work better for everyone.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Providence VA Medical Center NIH-funded |
| Lab location | 1 site (Providence, United States) |
| Project start | February 1, 2024 |
| Project end | January 31, 2029 |
| Funding year | 2025 |
| NIH project number | 5IK2CX002603-02 |
| Project ID | NIH-11043390 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are Veterans diagnosed with Major Depressive Disorder who have not found relief from conventional medication treatments.
✕Less likely to help
Patients with mild depression or those who have not been diagnosed with Major Depressive Disorder may not benefit from this research.
What this research studies
This research investigates the effectiveness of Transcranial Magnetic Stimulation (TMS) as a treatment for Major Depressive Disorder (MDD) in Veterans, particularly those who do not respond to traditional medications. TMS is a noninvasive therapy that uses magnetic fields to stimulate specific brain regions, aiming to improve mood and alleviate depressive symptoms. The study focuses on understanding the variability in how different patients respond to TMS, with the goal of optimizing treatment protocols and increasing the success rate of this therapy for Veterans. By analyzing clinical data, the research seeks to enhance the delivery of TMS and integrate it with measurement-based care approaches.
Why it matters
Potential benefit: If successful, this research could lead to more effective and personalized TMS treatments for Veterans suffering from depression, improving their quality of life.
How similar studies have gone: Previous research has shown promising results for TMS in treating depression, indicating that this approach has potential for success.
Where this research is happening
-
Providence VA Medical Center
Providence, United States Active
Researchers
- Principal investigator: Berlow, Yosef Alfred — Providence VA Medical Center
- Study coordinator: Berlow, Yosef Alfred
Related research
Other NIH-funded projects on the same topics.
-
Understanding how rTMS may reduce brain inflammation in depression and related brain conditions
This study tests whether a noninvasive brain stimulation (rTMS) changes brain inflammation in people with depression and certain brain conditions.
-
Modeling how brain stimulation helps depression in Veterans
A Veterans-focused project explores how transcranial magnetic stimulation (TMS) works for treating major depressive disorder and why responses vary, with the aim of making it more effective and accessible.
-
Using magnetic stimulation to improve brain barrier function in depression treatment
This study is looking at how a treatment called transcranial magnetic stimulation (TMS) might help improve the protective barrier in the brain for people with treatment-resistant depression, to see if fixing this barrier can lead to feeling better.
-
Combining brain stimulation and therapy to help veterans with chronic pain and depression
This study is exploring a new way to help veterans who are dealing with both chronic pain and depression by using a combination of brain stimulation and therapy to improve their pain and mood.
-
Biotype-based Personalization of Antidepressant Augmentation in Late-Life Depression
A multi-site study will test a computer-guided approach to choosing the best augmentation option for older adults with treatment-resistant depression.
-
Suubi-Mhealth: a mobile app to help Ugandan youth with HIV manage depression and ART adherence
A mobile app designed for 14–17 year olds in Uganda aims to support mental health and keep HIV treatment on track.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.